As-needed ICS-LABA in Mild Asthma: What Does the Evidence Say? Christian DomingoJordi RelloAna Sogo Current Opinion 04 October 2019 Pages: 1729 - 1737
Correction to: As-needed ICS-LABA in Mild Asthma: What Does the Evidence Say? Christian DomingoJordi RelloAna Sogo Correction 29 October 2019 Pages: 1739 - 1739
Targeting Granulocyte-Monocyte Colony-Stimulating Factor Signaling in Rheumatoid Arthritis: Future Prospects Chiara CrottiElena AgapeEnnio Giulio Favalli Review Article 04 September 2019 Pages: 1741 - 1755
Benefit:Risk Profile of Budesonide in Obstructive Airways Disease Donald P. TashkinBrian LipworthRalph Brattsand Review Article Open access 23 September 2019 Pages: 1757 - 1775
Lanadelumab: A Review in Hereditary Angioedema Yahiya Y. Syed Adis Drug Evaluation 27 September 2019 Pages: 1777 - 1784
Stiripentol: A Review in Dravet Syndrome James E. Frampton Adis Drug Evaluation 15 October 2019 Pages: 1785 - 1796
Pexidartinib: First Approval Yvette N. Lamb AdisInsight Report Open access 10 October 2019 Pages: 1805 - 1812
Darolutamide: First Approval Anthony MarkhamSean Duggan AdisInsight Report 11 October 2019 Pages: 1813 - 1818
Upadacitinib: First Approval Sean DugganSusan J. Keam AdisInsight Report 22 October 2019 Pages: 1819 - 1828
Correction to: Polatuzumab Vedotin: First Global Approval Emma D. Deeks Correction Open access 15 October 2019 Pages: 1829 - 1829